业务发展

业务发展

Business development

International Business

Contract sales service

The company has been specialized in marketing, promotion and sales of prescribed medicines for more than 20 years since its establishment, adopting two business models “direct academic promotion” and “agent promotion” which are commonly adopted in the medicine industry of China. The company can provide partner enterprises with various services such as product positioning and promotion, fast market coverage and hospital client development.

 

Now the company is cooperating with the following foreign enterprises:

Dr.Reddy's
GRUNBIOTICS
meiji
actavis

Import registration, acquisition of the right of sales

The company has been committed to introducing high-quality medicines from abroad into domestic market, boasting rich experience in terms of analysis of domestic medicine market, registration of medicines and market promotion. It can screen products suitable for the market of China for its foreign partners, and evaluate the registration feasibility and market potential of such products. Meanwhile, it can finish related issues concerning import registration and market promotion after the products are marketed.

Cooperation in research and development

The company is specialized in the development of high-end imitated medicines and innovative medicines with high technical barriers and clinical demands and values in the field of biological medicines. Through the strategies of cooperating in research and development with high-level scientific research institutions at home and abroad and directly introducing medicines from abroad, the company can quickly integrate the product and technology resources of each party to form a competitive product development model. The main models for its cooperation with foreign companies include,

Cooperation in research and development, authorized domestically; making joint investment, sharing the risks and profits;

Establishing a platform company for strategic cooperation;

Technical transfer.

External investment

Holding shares
Acquisition